Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 6, 2015-01 ,pp. : 509-522

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 6, 2015-09 ,pp. : 509-522

Bentham Science Publishers

Access to resources Recommend Favorite

Adipose Tissue and Bone Marrow as Sources for Cell-based Therapeutic Angiogenesis in Ischemic Tissues: Biological Foundation and Clinical Prospects for Age-related Vascular Disease

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 15, Iss. 2, 2015-08 ,pp. : 145-15

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Angiogenesis for Islet Revascularization

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 6, Iss. 2, 2006-04 ,pp. : 155-166

Bentham Science Publishers

Access to resources Recommend Favorite

CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34

By Miyata Yasuyoshi   Sagara Yuji   Watanabe Shin-ichi   Asai Akihiro   Matsuo Tomohiro   Ohba Kojiro   Hayashi Tomayoshi   Sakai Hideki  

Virchows Archiv, Vol. 463, Iss. 5, 2013-11 ,pp. : 673-679

Springer Publishing Company

Access to resources Recommend Favorite